Nestlé India and Dr Reddy’s Laboratories have established a joint venture to market their nutritional health products, vitamins, minerals, herbals, and supplements worldwide.

The joint company, which will have its headquarters in Hyderabad, will use Dr Reddy’s retail and distribution network to increase the nutritional solutions offered by Nestlé to consumers throughout the nation.

In this newly formed JV, Dr Reddy’s will hold 51%, whereas the remaining stake will be held by Nestle India. The company will have the option to increase its holding in the company to 60% after six years, while Dr Reddy’s will retain a minimum of 40%, despite Nestle India exercising its call option. 

Suresh Narayanan, chairman of Nestlé India, said, “We have been on a journey striving to add value to the lives of our consumers through powerful brands and products. This joint venture marks another significant step in that direction.”

The partners will license particular brands to operate the joint venture. Resources High Protein, Optifast, Osteo Bi-Flex, Ester-C, Nature’s Bounty, Peptamen, Resource Renal, and Resource Dialysis are just a few of the brands that Nestlé will license. 

Dr. Reddy’s will license the OTC and nutrition brands Rebalanz, Celevida, Antoxid, Kidrich-D3, and Becozinc. The joint venture is anticipated to begin operations in the first quarter of FY25.

MV Ramana, CEO – branded markets (India & Emerging Markets), at Dr Reddy’s, said, “This joint venture is a novel approach by two companies that have a shared purpose of good health. We are pleased to partner with Nestlé India to bring innovations from the Nestlé Health Science global portfolio to consumers in India.”